면역단백질 시장 : 제품, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Immunoprotein Market was valued at USD 19.64 billion in 2023, expected to reach USD 21.54 billion in 2024, and is projected to grow at a CAGR of 10.16%, to USD 38.67 billion by 2030.

Immunoprotein refers to proteins involved in the body's immune response, including immunoglobulins, cytokines, and complement proteins. The market scope for immunoproteins extends across diagnostics, therapeutics, and research applications. Necessity arises from their critical role in diagnosing and treating autoimmune diseases, allergies, infections, and cancer. In diagnostics, they serve as biomarkers to assess immune system function, while in therapeutics, monoclonal antibodies derived from immunoproteins are pivotal in targeted therapies. The end-use scope includes clinical laboratories, hospitals, and research institutions. Market growth is driven by advances in biotechnology and genomics, the increasing prevalence of chronic diseases, and demand for personalized medicine. Key growth opportunities lie in the development of novel therapies and point-of-care diagnostic tools leveraging immunoproteins. However, challenges such as high R&D costs, stringent regulatory frameworks, and issues of scalability and reproducibility hinder progress in the market. Limited standardization in testing methodologies can also affect the market's credibility and reliability. To seize emerging opportunities, stakeholders should invest in collaborative research to innovate safer, more effective immunoprotein-based solutions and enhance technological capabilities in bioinformatics to harness big data. Diversification into underexplored applications, such as neurodegenerative diseases, could offer untapped potential for growth. Additionally, expanding access to emerging markets can fuel demand where healthcare infrastructure is evolving. Innovation could focus on improving the specificity and sensitivity of immunoassays and developing cost-effective, portable diagnostic kits for lower-resource settings. The market nature is competitive, marked by strategic partnerships and acquisitions to bolster product pipelines and market share. By addressing current challenges through continuous innovation and strategic adaptation, businesses can leverage immunoproteins' full potential, solidifying their position in a dynamic healthcare landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoprotein Market

The Immunoprotein Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growth in incidence & prevalence of infectious and chronic diseases
  • Rising geriatric population across world and increase in diagnostic tests
  • Preferences for quick and accurate disease diagnosis
• Market Restraints
  • Immunoprotein tests are costly as compared to routine microbiology assays
• Market Opportunities
  • Technological advancements in immunodiagnostic instruments
  • Effective R&D efforts to discover therapeutics against critical disease
• Market Challenges
  • Availability of alternative testing approaches

Porter's Five Forces: A Strategic Tool for Navigating the Immunoprotein Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoprotein Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoprotein Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoprotein Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoprotein Market

A detailed market share analysis in the Immunoprotein Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoprotein Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoprotein Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoprotein Market

A strategic analysis of the Immunoprotein Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoprotein Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Celltrion Healthcare Co., Ltd., Eli Lilly and Company, Entera Health, Inc., Genentech, Inc. by F. Hoffmann-La Roche Ltd, Glaxosmithkline PLC, Merck KGaA, Neurobiologix, Inc., Novartis AG, Pfizer Inc., Progurt Inc., Samsung Biologics by Samsung Electronics Co., Ltd., SERO AS, TECHNOPATH Distribution Ltd. by Diploma PLC, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Immunoprotein Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, and Protein Electrophoresis.
• Based on Application, market is studied across Allergy Testing, Autoimmune Testing, Infectious Disease Testing, and Oncology & Endocrinology Testing.
• Based on End User, market is studied across Hospital & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growth in incidence & prevalence of infectious and chronic diseases
    • 5.1.1.2. Rising geriatric population across world and increase in diagnostic tests
    • 5.1.1.3. Preferences for quick and accurate disease diagnosis
  • 5.1.2. Restraints
    • 5.1.2.1. Immunoprotein tests are costly as compared to routine microbiology assays
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in immunodiagnostic instruments
    • 5.1.3.2. Effective R&D efforts to discover therapeutics against critical disease
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative testing approaches
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Immunoprotein Market, by Product

• 6.1. Introduction
• 6.2. C3
• 6.3. C4
• 6.4. Free Light Chains
• 6.5. Haptoglobin
• 6.6. IgA
• 6.7. IgE Specific
• 6.8. IgE Total
• 6.9. IgG
• 6.10. IgM
• 6.11. Immunofixation
• 6.12. Prealbumin
• 6.13. Protein Electrophoresis

7. Immunoprotein Market, by Application

• 7.1. Introduction
• 7.2. Allergy Testing
• 7.3. Autoimmune Testing
• 7.4. Infectious Disease Testing
• 7.5. Oncology & Endocrinology Testing

8. Immunoprotein Market, by End User

• 8.1. Introduction
• 8.2. Hospital & Clinics

9. Americas Immunoprotein Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Immunoprotein Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Immunoprotein Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amgen Inc.
• 2. Celltrion Healthcare Co., Ltd.
• 3. Eli Lilly and Company
• 4. Entera Health, Inc.
• 5. Genentech, Inc. by F. Hoffmann-La Roche Ltd
• 6. Glaxosmithkline PLC
• 7. Merck KGaA
• 8. Neurobiologix, Inc.
• 9. Novartis AG
• 10. Pfizer Inc.
• 11. Progurt Inc.
• 12. Samsung Biologics by Samsung Electronics Co., Ltd.
• 13. SERO AS
• 14. TECHNOPATH Distribution Ltd. by Diploma PLC
• 15. Teva Pharmaceutical Industries Ltd.